Soken Chemical & Engineering Co., Ltd. carries a market capitalization of 58.75B, placing it among publicly traded companies globally. Its enterprise value stands at 17.31B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 58.75B |
| Enterprise Value | 17.31B |
Soken Chemical & Engineering Co., Ltd. currently has 16.58M shares outstanding.
| Shares Outstanding | 16.58M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Soken Chemical & Engineering Co., Ltd. trades at a trailing price-to-earnings ratio of 21.32. The price-to-sales ratio is 1.21, and the price-to-book ratio stands at 0.96.
| PE Ratio | 21.32 |
| PS Ratio | 1.21 |
| PB Ratio | 0.96 |
| P/TBV Ratio | 0.75 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
On an enterprise value basis, Soken Chemical & Engineering Co., Ltd. trades at an EV/EBITDA multiple of 8.02 and an EV/FCF ratio of 535.72. The EV/Sales ratio of 0.78 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 8.02 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.78 |
| EV / EBITDA | 8.02 |
| EV / EBIT | 8.02 |
| EV / FCF | 535.72 |
Soken Chemical & Engineering Co., Ltd. maintains a current ratio of 2.21, meaning it holds 2.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 13.70, indicating elevated leverage, while an interest coverage ratio of 41.12 demonstrates strong ability to service its debt obligations.
| Current Ratio | 2.21 |
| Quick Ratio | 0.96 |
| Debt / Equity | 13.70 |
| Debt / EBITDA | 2.32 |
| Interest Coverage | 41.12 |
Soken Chemical & Engineering Co., Ltd. posts a return on equity of 4.79 and a return on invested capital of 3.40.
| Return on Equity (ROE) | 4.79 |
| Return on Assets (ROA) | 2.41 |
| Return on Invested Capital (ROIC) | 3.40 |
| Return on Capital Employed (ROCE) | 4.15 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 2.65 |
Over the trailing twelve months, Soken Chemical & Engineering Co., Ltd. has paid 782.81M in income taxes, reflecting an effective tax rate of 38.42.
| Income Tax | 782.81M |
| Effective Tax Rate | 38.42 |
Soken Chemical & Engineering Co., Ltd.'s stock has gained approximately 135.52894% over the past 52 weeks. The 50-day moving average sits at 3,396.10, while the 200-day moving average is 2,910.52.
| Beta (5Y) | N/A |
| 52-Week Price Change | 135.52894% |
| 50-Day Moving Average | 3,396.10 |
| 200-Day Moving Average | 2,910.52 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Soken Chemical & Engineering Co., Ltd. generated 22.06B in revenue and converted that into 1.25B in net income, yielding earnings per share of 75.75. EBITDA reached 2.16B, while operating income came in at 2.16B.
| Revenue | 22.06B |
| Gross Profit | 6.69B |
| Operating Income | 2.16B |
| Pretax Income | 2.04B |
| Net Income | 1.25B |
| EBITDA | 2.16B |
| EBIT | 2.16B |
| Earnings Per Share (EPS) | 75.75 |
Soken Chemical & Engineering Co., Ltd. holds 14.44B in cash and equivalents against 5.00B in total debt, resulting in a net debt position of -2.94B. Total book value stands at 27.82B, with working capital of 18.27B providing operational flexibility.
| Cash & Cash Equivalents | 14.44B |
| Total Debt | 5.00B |
| Net Debt | -2.94B |
| Equity (Book Value) | 27.82B |
| Book Value Per Share | 1,679.76 |
| Working Capital | 18.27B |
Soken Chemical & Engineering Co., Ltd. operates with a gross margin of 30.30, reflecting its pricing power and cost economics. The operating margin of 9.78 and net profit margin of 5.69 provide insight into operational efficiency.
| Gross Margin | 30.30 |
| Operating Margin | 9.78 |
| Pretax Margin | 9.23 |
| Profit Margin | 5.69 |
| EBITDA Margin | 9.78 |
Soken Chemical & Engineering Co., Ltd.'s most recent stock split took place on March 28, 2025 with a 1:2 split ratio.
| Last Split Date | 3/28/2025 |
| Split Ratio | 1:2 |
Soken Chemical & Engineering Co., Ltd. posts an Altman Z-Score of 2.42, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 2.42 |